There are 2789 resources available
1236P - Poziotinib in NSCLC harbouring EGFR or HER2 exon 20 insertion mutation
Presenter: Arsela Prelaj
Session: ePoster Display
1237P - Gut microbiome profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
Presenter: Woraseth Saifon
Session: ePoster Display
1238P - AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients
Presenter: Baohui Han
Session: ePoster Display
1261P - Trastuzumab/pertuzumab combination therapy in advanced pre-treated HER2-mutated non-small cell lung cancer: Results of a DRUP trial cohort
Presenter: Jade van Berge Henegouwen
Session: ePoster Display
1262P - ROS1 resistance mutations and co-occurring genetic alterations to the ROS1 protein-tyrosine kinase inhibitors (crizotinib) in lung cancer
Presenter: Yuqing Weng
Session: ePoster Display
1265P - Combined detection of tumor markers and ctDNA in cerebrospinal fluid: A good strategy in diagnosis of leptomeningeal metastases
Presenter: Yong Wang
Session: ePoster Display
1266P - Genetic profiling of cell-free DNA from pleural effusion in advanced lung cancer as a surrogate for tumor tissue and revealed additional clinical actionable targets
Presenter: Hai-Yan Tu
Session: ePoster Display
1267P - Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
Presenter: Mariona Riudavets Melia
Session: ePoster Display
1268P - Real-time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC
Presenter: Marta Garcia De Herreros
Session: ePoster Display